Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 2081 - ELECTRONIC PRESCRIPTION MONITORING PROGRAM - LONG TERM CARE › Section 2081.20 - Definitions and Incorporation by Reference

Current through Register Vol. 48, No. 28, July 12, 2024
No incorporations by reference in this Part include any later
				amendments or editions. The definitions that apply to this Part are those found
				in the Act and those in this Section.
"Act" means the Illinois Controlled Substances Act
				[720 ILCS
				570 ].
"Birth Date" means the medication recipient's birth
				date.
"Central Repository" means a place designated by the Department
				where Schedule II, III, IV and V drug data is stored or housed.
"
Clinical Director" means a DHS administrative employee
				licensed to either prescribe or dispense controlled substances who shall run
				the clinical aspects of the DHS Prescription Monitoring Program and its
				Prescription Information Library
[720 ILCS
				570/102 (d-5)].
"Controlled Substance" means a drug, substance, or
				immediate precursor in the Schedules of Article II of the Illinois Controlled
				Substances Act, or a drug or other substance, or immediate precursor,
				designated as a controlled substance by the DHS
[720 ILCS
				570/102(f) ].
"DEA Number" means the United States Drug Enforcement Agency
				prescriber or dispenser registration number.
"Department" or "DHS" means the Illinois Department of Human
				Services, or its successor agency.
"Dispenser" means any practitioner
or pharmacy
that dispenses a controlled substance to an ultimate user or research
				subject by or pursuant to the lawful order of a prescriber
[720 ILCS
				570/102(p) and (q) ].
"DPH" means the Illinois Department of Public Health.
"Electronic Device" means using a computer system to transmit
				prescriptions from a prescriber directly to a dispenser.
"Exempt Prescribers in Hospitals and Institutions" means
				prescribers in hospitals or institutions licensed under the Hospital Licensing
				Act [210
				ILCS 85 ] who authorize the administration or
				dispensing of Schedule II drugs within the hospital or institution, for
				consumption within the hospital or institution (e.g., controlled substance
				prescriptions when a prescriber does not maintain his or her own DEA and State
				controlled substance license, but prescribes based upon the institution's
				(hospital's) controlled substance licenses).
"Facsimile Equipment" means any device capable of sending or
				receiving facsimiles of documents through connection with a telecommunications
				network.
"HFS" means the Illinois Department of Healthcare and Family
				Services.
"Illinois Controlled Substances License Number" means the State
				license number issued by the Illinois Department of Financial and Professional
				Regulation (DFPR) permitting prescribers to possess, prescribe or dispense, and
				permitting dispensers to possess and dispense, controlled substances in
				Illinois pursuant to the Controlled Substances Act (see 77 Ill. Adm. Code
				3100).
"Licensed Healthcare Provider" means any individual who meets
				the professional licensing requirements and follows the standards set forth by
				DFPR and are authorized to prescribe or dispense controlled substances within
				Illinois.
"Long Term Care" or "LTC" means:
any facility defined by Section 1-113 of the Nursing Home Care
				Act; and
any skilled nursing facility or a nursing facility that meets
				the requirements of section 1819(a), (b), (c) and (d) or section 1919(a), (b),
				(c) and (d) of the Social Security Act (42 U.S.C. 1395i-3(a), (b), (c) and
				(d) and
				1396r(a),
				(b), (c) and (d)) .
"Long Term Care Pharmacy" or "LTC Pharmacy" means those
				pharmacies that, either as a primary or secondary focus, provide prescription
				services to those inpatient institutions licensed as LTC facilities by
				DPH.
"Mid-level Practitioner" means:
a physician assistant who has been delegated authority
				to prescribe through a written delegation of authority by a physician licensed
				to practice medicine in all of its branches, in accordance with Section
				7.5 of the Physician Assistant
				Practice Act of 1987
[225 ILCS 95 ];
an advanced practice registered nurse who has been
				delegated authority to prescribe through a written delegation of authority by a
				physician licensed to practice medicine in all of its branches or by a
				podiatric physician, in accordance with Section 65-40 of the Nurse Practice
				Act
[225 ILCS 65 ];
an advanced practice registered nurse certified as a
				nurse practitioner, nurse midwife, or clinical nurse specialist who has been
				granted authority to prescribe by a hospital affiliate in accordance with
				Section 65-45 of the Nurse Practice Act;
an animal euthanasia agency; or
a prescribing psychologist.
[720 ILCS
				570/102 (z-10)]
"National Drug Code Identification Number" or "NDC
				Identification Number" means the number used to provide uniform product
				identification for all substances recognized as drugs in the United States
				Pharmacopoeia National Formulary, USP31-NF26 (US Pharmacopoeial Convention,
				12601 Twinbrook Parkway, Rockville, Maryland 20852 (2013)).
"Patient ID" means the identification of the individual
				receiving the medication or the responsible individual obtaining the medication
				on behalf of the recipient or the owner of the animal. The standards for
				establishing patient ID for the purpose of proper filling of a prescription are
				established by 77 Ill. Adm. Code
				2080.70(d).
"Patient Location Code" means the portion of a LTC pharmacy's
				system of electronic files that identifies with which LTC facility, and what
				classification of care, the individual patient is associated.
"Prescribed" means ordered by a prescriber verbally,
				electronically or in writing.
"Prescriber" means the healthcare professional that is
				authorized to prescribe medications as set forth in the various professional
				practices of the State of Illinois.
"Prescription Information Library" or "PIL" means an
				electronic library containing 12 months of controlled substance
,
				retail, prescription
information
that is accessible only by
				prescribers and dispensers for patient treatment usage [720 ILCS
				570/102 (nn-5)].
"Prescription Monitoring Program" or "PMP" means the
				entity that collects, tracks, and stores reported data on controlled substances
				and select drugs
[720 ILCS 570/102
				(nn-10)]
.
"Prescription Monitoring Program Advisory Committee" or "PMPAC"
				means a committee consisting of licensed healthcare providers representing all
				professions that are licensed to prescribe or dispense controlled substances.
				The committee serves in a consultant context regarding longitudinal evaluations
				of compliance with evidence based clinical practice and controlled substances.
				The committee makes recommendations regarding scheduling of controlled
				substances and recommendations concerning continuing education designed at
				improving the health and safety of the citizens of Illinois regarding
				pharmacotherapies of controlled substances (e.g., the choice of medications,
				the frequency of refills, concomitant pharmacotherapies of other medications,
				all of which affect clinical response and possible dependency on those
				therapies).
"Quantities of a Controlled Substance Dispensed" means the
				total of a National Drug Code product dispensed whether it is in a solid unit
				such as a tablet or capsule, in a liquid unit such as milliliters, or in
				another unit as specified within the product identification.
"Recipient's Name" means the given or common name of a person
				who is the intended user of a dispensed medication. It may also mean the
				species or common name or common given name of an animal that is the intended
				user of a dispensed medication. If an animal's name is entered, the owner's
				name is required also.
"Schedule Drug" means any substances listed in the federal
				Controlled Substances Act (21 U.S.C. 812) or the Illinois
				Controlled Substances Act [720 ILCS 570 ] or by the
				Department pursuant to its authority under Section 202 of the Illinois
				Controlled Substances Act. Schedule, I, II, III, IV and V substances are listed
				in section 812 of the federal Controlled Substances Act (21 U.S.C. 812(b)(2),
				(b)(3), (b)(4), (b)(5) and (c)) and Sections
				204, 206, 208, 210 and 212 of the Illinois Controlled Substances Act.
"Sex" means the medication recipient's biological status of
				being male or female at birth.